<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We investigated the prognostic role of <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> by delayed enhancement (DE) cardiovascular magnetic resonance (CMR) in nonischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (NICM) patients with no or mild symptoms of <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A prospective cohort of 125 NICM patients (82 males, age 59±14years, mean±SD) with echocardiographic evidence of left ventricular (LV) systolic dysfunction (mean ejection-fraction 33±10%), without (stage B) or with history of mild HF symptoms (stage C, NYHA classes I-II) was enrolled </plain></SENT>
<SENT sid="2" pm="."><plain>The end-point was a composite of cardiac <z:hpo ids='HP_0011420'>death</z:hpo> and HF hospitalization </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Fifty (40%) patients showed myocardial DE, representing 12±7% of LV mass </plain></SENT>
<SENT sid="4" pm="."><plain>During a median follow-up of 14.2months, 16 (32%) patients with DE experienced a composite event versus only 6 (8%) patients without DE (Kaplan-Meier survival curve, p=0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>After correction for age, CMR-derived LV and right ventricular volumes, echocardiographic measurements of LV diastolic function and Doppler-estimated systolic pulmonary artery pressure, the presence of DE remained a strong and independent predictor of cardiac <z:hpo ids='HP_0011420'>death</z:hpo> or HF hospitalization (hazard ratio: 5.32, 95% confidence intervals 1.60 to 17.63, p=0.006) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In NICM patients with no or mild HF symptoms, the presence of myocardial DE is a strong predictor of worse clinical outcome even after correction for other established prognostic determinants </plain></SENT>
<SENT sid="7" pm="."><plain>Contrast-enhanced CMR may be useful in prognostic stratification from the early stages of NICM </plain></SENT>
</text></document>